SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD. Funds and ETFs Shenzhen Kangtai Biological Products Co., Ltd.
Equities
300601
CNE100002Q33
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.44 CNY | -0.06% |
|
-4.44% | -35.76% |
ETFs positioned on Shenzhen Kangtai Biological Products Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.60% | 1 M€ | -18.21% | - | |
| 0.06% | 35 M€ | -5.85% | - | |
| 0.00% | 4 M€ | -4.41% | - | |
| 0.00% | 451 M€ | +6.10% | - | |
| 0.00% | 2,838 M€ | +8.61% | - | |
| 0.00% | 152 M€ | +5.71% | - | |
| 0.00% | 35 M€ | +5.55% | - | |
| 0.00% | 36 M€ | +9.83% | - | |
| 0.00% | 414 M€ | +10.00% | - | |
| 0.00% | 40 M€ | +6.57% | - | |
| 0.00% | 324 M€ | +6.65% | - | |
| 0.00% | 17 M€ | +3.59% | - | |
| 0.00% | 32 M€ | +4.30% | - | |
| 0.00% | 104 M€ | +4.07% | - | |
| 0.00% | 7 M€ | +5.53% | - | |
| 0.00% | 8 M€ | +1.08% | - | |
| 0.00% | 55 M€ | +0.75% | - | |
| 0.00% | 15 M€ | +15.25% |
Shenzhen Kangtai Biological Products Co. specialises in the research, development and marketing of human vaccines. Products include vaccines against hepatitis B, haemophilus influenzae type B, measles and rubella.
Sector
Pharmaceuticals
Calendar
2024-08-27
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
17.44
CNY
Average target price
30.72
CNY
Spread / Average Target
+76.12%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -35.76% | 2.69B | |
| +0.82% | 91.94B | |
| -1.32% | 38.74B | |
| -12.88% | 32.82B | |
| +64.26% | 26.66B | |
| -16.31% | 15.32B | |
| -11.38% | 11.65B | |
| +173.10% | 10.37B | |
| -49.84% | 10.12B | |
| +3.75% | 9.06B |
- Stock Market
- Equities
- 300601 Stock
- Funds and ETFs Shenzhen Kangtai Biological Products Co., Ltd.
